Completed
Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device
NCT05368623
- Conditions
- Cardiovascular Diseases, Diabetes, Diabetes Complications, +12 more
- Locations
-
- Clinical Research Organization Los Angeles, California, United States
- Clinical Research Organization Chicago, Illinois, United States
- Clinical Research Organization Houston, Texas, United States